Typhim VI 25 MCG/0.5 ML syrng 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FJTS9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,798
Award facts
- Contract value 100% obligated
- $13,798.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,798.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes. The award, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, represents a competitively awarded non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The DLA Troop Support Medical IDC enables the company to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This current delivery order for typhoid vaccine syringes supports the Defense Health Agency and broader Department of Defense medical supply requirements. The contract demonstrates AmerisourceBergen's established capability to fulfill federal medical procurement needs through open competition and its role as a key vendor within the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FJTS9?
SPE2DB25FJTS9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FJTS9 worth?
The government has obligated $13,798 on SPE2DB25FJTS9.
Is contract SPE2DB25FJTS9 an order under another contract?
Yes. SPE2DB25FJTS9 is a delivery order under SPE2DB22D2005, an indefinite delivery contract.
Was contract SPE2DB25FJTS9 competed?
The extent of competition for SPE2DB25FJTS9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award